Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. - Wikidata - awgldk - TriplyDB

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

http://www.wikidata.org/entity/Q30478184

about

Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and Cancer Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy Regulation of ovarian cancer stem cells or tumor-initiating cells Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor inva In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147 High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.Stem cell pathways contribute to clinical chemoresistance in ovarian cancer The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model.Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Ovarian cancer stem cells: are they real and why are they important?Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.Ovarian cancer stem cell markers: prognostic and therapeutic implications.Mechanisms involved in enhancement of the expression and function of aggrecanases by hyaluronan oligosaccharides Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.Emmprin and KSHV: new partners in viral cancer pathogenesis.HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.Therapeutic targeting of hyaluronan in the tumor stroma.Lung cancer stem cells and implications for future therapeutics.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Targeting hyaluronic acid family for cancer chemoprevention and therapy.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib.Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.

P2860

Q21131129-EA83DAC2-39AA-4E27-86AA-461BADCF3062 Q26782792-6EB6525E-87CF-41B0-B6DA-617AAF821011 Q26784055-C6CA2F10-339A-4FAD-9A86-D723CCB5864D Q26853096-309D8594-5E7F-4DCF-A740-0FFB8E3E99F5 Q28394879-D464A0C8-9338-4DF6-800C-038918E6D2E4 Q28482047-A4A4C051-B156-4828-BF86-6DE2DF1D188A Q28487341-6DB84460-EB6C-4A41-8E3C-48465C0797D1 Q30357883-EE567C4A-33AD-4E4A-AA01-66FC4629CA58 Q30409503-241506CF-04D1-45EB-BB92-8C8FA0BEA1E1 Q30418735-56027F1E-4557-4371-AFA0-D1001B31040B Q30431290-4BBD2E22-CF8A-4B53-91AA-BEA97444B016 Q34092005-93761F87-1E09-4402-891C-EDCE87D1216E Q34285178-CFCBE19C-1638-4976-90A7-277EE1F68A21 Q34300214-85C3083A-1083-4DC9-BF44-89B5324AA42D Q34420393-D6F44173-F60C-42E7-BC52-72264970074D Q34448718-428D022E-9EEE-46C7-8CE7-8E3A5FEC7547 Q34874835-EFE22318-28E3-4583-83ED-36494589DACE Q35047699-E0B94BD4-98AD-46A6-ADCB-D3146ABD2C26 Q35402326-32B83877-449C-4794-ADCB-B9C5BF1EB084 Q35606242-4D578067-6191-4F96-B93E-13A23DB485FF Q35621664-5A0394C7-BC59-4506-9ABB-2BD1D7737C9A Q35832214-A3B21FA6-2E9D-4174-AABC-0371DF404EA1 Q36014411-C023BCCB-CD46-4416-8B9E-C0EDE609B945 Q36294870-55362D5B-17D3-4E3B-B3B1-86392C390E9B Q36396500-5AEB5D8B-CE0B-4C1C-9833-D85A144F3466 Q36562166-5C2024DF-69C9-4277-8A34-9F98BFFA3398 Q36582881-A6844A51-5AA5-4B98-91F6-85F0360CC7A4 Q36856835-2A9D1D10-4675-486F-B188-AD84C21E04B0 Q37057685-C9F5254B-4FD9-4871-B556-2D674A04F316 Q37416242-1B47061D-5803-4B3F-841E-DFCA05AE48CD Q37591395-3464EF84-F112-44E7-83F8-5AA785458174 Q37608433-6505C3AF-83F5-4E60-B97B-A264DC67C22E Q37716449-E75ABC77-4205-48EF-905D-C5A92640D5A8 Q38161392-877A2755-D64A-483A-8380-8A7A9FBA59BF Q38189297-7615E36E-3D61-450E-BA15-07F79B51B0E4 Q38203882-F9B420CC-4D92-4C6E-B8E5-A877927C0186 Q38235792-920EF4AE-50F8-46F1-B632-76B2F219F656 Q38476060-2E984C64-3A45-418A-94F0-20EB39247DC8 Q38818540-F2D312D4-85D6-4271-8D7D-E184A3D30ED8 Q38838567-74618EA5-595D-49BF-9B0B-CBA79994A687

P2860

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

http://www.wikidata.org/entity/Q30478184

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@ast

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@en

type

label

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@ast

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@en

prefLabel

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@ast

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@en

P1433

Q30478184-3CD63671-DED9-4446-891F-690D65C4FB5E

P1476

Q30478184-E8101011-8003-4A54-88E9-0A591F4E4F8A

P2093

Q30478184-0E0400A6-F96B-4D64-B3E6-C27BFBAAEDB6

Q30478184-5A49CD57-A66B-43C9-96F0-3A13F453B959

Q30478184-80F03934-DF46-42C2-8012-E8736BBFC537

Q30478184-99154CDC-5D8C-49C5-BADC-ABA54285787A

Q30478184-E16C949A-FE59-4D16-BE31-A11018266304

Q30478184-EDE8FBF5-7F2E-4665-A425-78B2AB378F10

P2860

Q30478184-0233F7A6-94D1-4A0C-AD51-719D99D7B817

Q30478184-0D3FD019-FC32-4B9D-9ADF-FEE8DA7ECAC8

Q30478184-11793A07-C8B0-4223-ABE3-44A8F4AD1AFD

Q30478184-118B6C96-15DC-429E-A8A2-A1A67FACEBF4

Q30478184-1615A2D2-8408-4904-A608-8F119CFDB8FF

Q30478184-212A0A2E-909E-4A54-A398-734E16C00CB4

Q30478184-251EFC6C-156F-43AB-8964-2B9B80BA8380

Q30478184-29CED622-11D2-4DAD-B4D7-95D0A78537D7

Q30478184-30B599DE-276D-4E7B-823B-86887E0E4DBC

Q30478184-32B9978B-3763-4979-BD0A-A45DF6950E16

P304

Q30478184-FA84A2C5-2662-4E90-8F16-0737DE808485

P31

Q30478184-A85789A9-3ADA-42FA-81DD-AACB66895E99

P356

Q30478184-076419FD-18D3-4CE8-9669-358CF1860935

P407

Q30478184-75A494BF-8AA7-424B-9CAF-BA5FA9C893A8

P433

Q30478184-D4B0C05D-F2C1-48B8-B30F-0C652C9DA38C

P478

Q30478184-795A5EF9-CDE0-4867-AE6D-269969DEEA3E

P577

Q30478184-F4A1D2CD-BF4D-410C-B94D-D8912D10FFB5

P698

Q30478184-57A24568-CAA3-415D-9CDA-C6BAD66AAC07

P921

Q30478184-82682AFE-A936-46E7-8B47-32C2F267400C

P932

Q30478184-DCCFDC55-B006-4F53-90E5-EFEF04707D9A

P356

1078-0432.CCR-09-2317

P1433

Clinical Cancer Research

P1476

Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.

@en

P2093

Bryan P Toole

http://www.w3.org/2001/XMLSchema#string

G Daniel Grass

http://www.w3.org/2001/XMLSchema#string

Lauren B Tolliver

http://www.w3.org/2001/XMLSchema#string

Lu Dai

http://www.w3.org/2001/XMLSchema#string

Mark G Slomiany

http://www.w3.org/2001/XMLSchema#string

Yiping Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

The epithelial-mesenchymal transition generates cells with properties of stem cells

Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth

Molecular definition of breast tumor heterogeneity

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

Cancer stem cells: models and concepts

Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.

Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells

P304

7593-7601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-2317

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19996211

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide

P932

2794991

http://www.w3.org/2001/XMLSchema#string